Rilonacept (interleukin‐1 trap) for prevention of gout flares during initiation of uric acid–lowering therapy: Results from a phase III randomized, double‐blind, placebo‐controlled, confirmatory efficacy study
Year: 2012
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Arthritis Care & Research
DOI: 10.1002/acr.21690
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2054682176
